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Abstract: The present study investigated the effect of ingesting caffeine-dose-matched anhydrous
caffeine or coffee on the performance of repeated sprints. Twelve recreationally active males
(mean ± SD age: 22 ± 2 years, height: 1.78 ± 0.07 m, body mass: 81 ± 16 kg) completed eighteen
4 s sprints with 116 s recovery on a cycle ergometer on four separate occasions in a double-blind,
randomised, counterbalanced crossover design. Participants ingested either 3 mg·kg−1 of caffeine
(CAF), 0.09 g·kg−1 coffee, which provided 3 mg·kg−1 of caffeine (COF), a taste-matched placebo
beverage (PLA), or a control condition (CON) 45 min prior to commencing the exercise protocol.
Peak and mean power output and rating of perceived exertion (RPE) were recorded for each sprint.
There were no significant differences in peak power output (CAF: 949± 199 W, COF: 949± 174 W, PLA:
971 ± 149 W and CON: 975 ± 170 W; p = 0.872; η2P = 0.02) or mean power output (CAF: 873 ± 172 W,
COF: 862± 44 W, PLA: 887± 119 W and CON: 892± 143 W; p = 0.819; η2P = 0.03) between experimental
conditions. Mean RPE was similar for all trials (CAF: 11 ± 2, COF: 11 ± 2, PLA: 11 ± 2 and CON:
11 ± 2; p = 0.927; η2P = 0.01). Neither the ingestion of COF or CAF improved repeated sprint cycling
performance in relatively untrained males.
Keywords: caffeine; coffee; repeated sprints; cycling
1. Introduction
The majority of research into caffeine as an ergogenic aid has focused on endurance performance,
although there is also evidence to suggest that caffeine positively affects short-term high-intensity
performance [1]. A number of studies report significant improvements in short-term high-intensity [2–4]
and repeated-sprint performance [5–7] following the ingestion of between 5 and 9 mg·kg−1 of caffeine.
However, Paton et al. [8] (6 mg·kg−1 of caffeine) and Glaister et al. [9] (2–10 mg·kg−1 of caffeine)
reported that caffeine had no effect on repeated sprint performance.
The leading hypothesis as to how caffeine could have an ergogenic effect during anaerobic exercise
is via the facilitation of central effects by antagonising adenosine receptors, thereby inhibiting the
negative effects of adenosine on neurotransmission, arousal and pain perception [10]. The ingestion
of caffeine also stimulates the central nervous system which increases alertness and focus [11].
A number of other possible mechanisms have been attributed to the ergogenic effects of caffeine
including central nervous system facilitation [12] and mobilisation of intracellular calcium [13],
as Tarnopolsky and Cupido [14] suggested that caffeine increases calcium release from the sarcoplasmic
reticulum. Furthermore, Tarnopolsky [15] suggested that caffeine increases motor-unit recruitment,
contractility of skeletal muscle and force production by enhanced neuromuscular transmission,
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and therefore maximal muscle activation. There is also evidence to suggest that caffeine may enrich
the sodium-potassium pump within skeletal muscle and enhance excitation contraction coupling [10],
which aids improvements in physical performance [16]. However, Astorino and Roberson [11]
concluded that the mechanism by which caffeine provides an ergogenic effect in short-term,
high intensity exercise is likely to be multifactorial. Central factors such as adenosine antagonism
may be the most probable mechanism, with alterations in perceived exertion, reaction time, cognition,
and mood also having an influence on performance.
The predominant dietary source of caffeine is coffee [17], although there is debate about the
effectiveness of coffee as a performance enhancer. Costill, Dalsky and Fink [18] and Wiles et al. [19]
concluded that coffee consumption enhances high-intensity exercise performance. However,
Graham et al. [20] suggested that only anhydrous caffeine improved exercise performance when
running at 85% VO2max and proposed that chlorogenic acids, and possibly other ingredients within
the coffee, nullified the ergogenic benefits of caffeine. More recently, Hodgson, Randell and
Jeukendrup [21] reported that during a cycling time trial, dose matched coffee and caffeine ingestion
were beneficial to exercise performance by similar magnitudes. Furthermore, Trexler et al. [22]
concluded that coffee is a suitable source of caffeine to improve repeated sprint performance.
The inconsistency in performance outcomes of coffee between studies may be due to brands of
coffee used as there has been shown to be significant variances in chlorogenic acid content [23],
as well as exercise modality [24], caffeine solution strengths within the coffee, and participant
training status [25]. Furthermore, the majority of the aforementioned investigations focused on
endurance-based protocols. In contrast, Wiles et al. [19] observed that 1500 m running performance
improved significantly following the ingestion of coffee. Therefore, both the coffee and caffeine have
the potential to improve repeated sprint performance during cycling. Consequently, the aim of the
present study was to determine the effect of ingesting caffeine-dose-matched anhydrous caffeine or
coffee on the performance of repeated sprints on a cycle ergometer.
2. Materials and Methods
2.1. Study Design
Participants completed eighteen 4 s sprints separated by 116 s recovery on a cycle ergometer
(WattBike Pro, WattBike Ltd., Nottingham, UK) on four separate occasions in a double-blind,
randomised, counterbalanced crossover design following the ingestion of caffeine, caffeinated
coffee, a placebo beverage or a control condition. The exercise protocol was designed to replicate
team-sport-based exercise [26]. The study was approved by the local Ethics Committee and undertaken
in accordance with the Declaration of Helsinki.
2.2. Participants
Twelve recreationally active males (mean± SD age: 22± 2 years, height: 1.78± 0.07 m, body mass:
81 ± 16 kg) were made fully aware of the exact procedures, including any risks and benefits of
participation in the study before providing written informed consent.
2.3. Experimental Trial
Prior to the first session, a familiarisation session was conducted where the testing protocol and
equipment was explained and practiced. Participants arrived at the laboratory at least 3 h postprandial
having abstained from caffeine, alcohol, and strenuous activity for 12 h, and recorded their dietary
intake for 48 h before the initial experimental trial. This diet was then replicated before the subsequent
experimental trials. Participants consumed the experimental beverages 45 min prior to exercise,
in agreement with previous studies [27]. Participants ingested either 3 mg·kg−1 of caffeine (MyProtein;
Manchester, UK; CAF), 0.09 g·kg−1 coffee (Nescafé Original, Nestlé, Gatwick, UK), which contained
3 mg·kg−1 of caffeine (COF), a taste-matched placebo beverage (Whole Earth Organic coffee alternative,
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Wessanen, Surrey, UK) with no caffeine content (0 mg·kg−1; PLA), or a control condition where no
beverage was ingested (CON) 45 min prior to commencing the exercise protocol. Nescafé original
coffee was used as Hodgson, et al. [21] reported that it contains 3.4 g of caffeine per 100 g of coffee,
meaning that each participant consumed 0.09 g·kg−1 of coffee to achieve the 3 mg·kg−1 of caffeine
required. All substances were dissolved in 300 mL of hot water (62.4 ± 1.4 ◦C). A dose of 3 mg·kg−1 of
caffeine has previously been demonstrated to provide an ergogenic effect [28].
Participants completed a repeated sprint test, based on the protocol described by Zimmermann
and Landers [29] on a cycle ergometer. Participants adjusted the saddle and handle bars for comfort
and these adjustments remained consistent for all trials. Participants performed a two-minute warm
up at 70–80 rpm with air resistance of “level 1” immediately followed by eighteen 4 s maximal
sprints at air brake resistance level 3, magnet setting 1 [30]. Each 4-s sprint was followed by 96 s of
active recovery (continuous cycling at 70 rpm) and then 20 s of passive recovery (rest). Peak and
mean power output and rating of perceived exertion (RPE; Borg [31]) were recorded for each sprint.
A capillary blood sample was then drawn from the index finger for determination of blood lactate
concentration (Biosen HbA1c, EKF-diagnostic GmbH, Magdeburg, Germany) immediately prior to
the start (post-warm-up) and at the completion of each trial in order to assess physiological stress.
Participants received no feedback about their performance until all three trials were completed; this was
to reduce bias, as was the procedure in previous studies [21].
2.4. Statistical Analysis
Data are reported as the mean ± the standard deviation (SD). In addition, as the responses to
low doses of caffeine are often variable and athletes need to determine whether the ingestion of
caffeine is ergogenic on an individual basis [28], the mean individual performances for each condition
are also presented. The Shapiro-Wilk test was applied to the data in order to assess for a normal
distribution. All variables were analysed with a two-way ANOVA with repeated measures, with the
exception of overall peak and mean power output, which were assessed using a one-way ANOVA
with repeated measures. Sphericity was analysed by Mauchly’s test of sphericity followed by the
Greenhouse-Geisser adjustment where required. Where any differences were identified, pairwise
comparisons with Bonferroni correction were used in order to show where they lay. All statistical
procedures were conducted using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk,
NY, USA). An alpha level of p < 0.05 was considered statistically significant and interpretations were
made in accordance with the suggestions by Curran-Everett and Benos [32]. Furthermore, effect sizes
using partial eta squared (η2P) were calculated, and were defined as trivial, small, moderate or large [33].
3. Results
There were no significant differences in peak power output (F3,33 = 0.233; p = 0.872; η2P = 0.03;
Figure 1) or mean power output (F3,33 = 0.308; p = 0.819; η2P = 0.03; Figure 2) between experimental
conditions. In addition, there was a trend for peak power output (F17,187 = 1.582; p = 0.072; η2P = 0.13)
and mean power output (F5,51 = 2.155; p = 0.078; η2P = 0.16) to decline throughout the protocol. However,
there were no significant differences in the fatigue index (COF: 5%, CAF: −2%, PLA: 2%, CON: 12%;
F3,33 = 1.391; p = 0.263; η2P = 0.11) and peak power observed during the first sprint (COF: 958 ± 179 W,
CAF: 1001 ± 167W, PLA: 976 ± 224 W, CON: 911 ± 137 W; F3,33 = 1.278; p = 0.298; η2P = 0.10) during
each condition. Analysis of the peak power output (F3,33 = 0.232; p = 0.873; η2P = 0.02; Figure 3a) and
mean power output (F3,33 = 0.307; p = 0.820; η2P = 0.03; Figure 3b) for each third of the exercise protocol
revealed no significant differences between conditions, and there was no main effect of time with
regards to peak power output (F2,22 = 1.180; p = 0.326; η2P = 0.10), although mean power output was
greater in the first third of the protocol compared with the second (F2,22 = 4.694; p = 0.020; η2P = 0.30).
Furthermore, there were no significant differences in overall peak power output (COF: 949 ± 174 W,
CAF: 949 ± 199 W, PLA: 971 ± 149 W, CON: 975 ± 170 W; F3,33 = 0.233; p = 0.872; η2P = 0.02) or
mean power output (COF: 862 ± 44 W, CAF: 873 ± 172 W, PLA: 887 ± 119 W, CON: 892 ± 143 W;
Sports 2016, 4, 45 4 of 9
F3,33 = 0.308; p = 0.819; η2P = 0.03) between experimental conditions. In addition, there was large
variation between participants for peak power output (Figure 4a) and mean power output (Figure 4b).
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Figure 2. Mean power output during repeated cycling sprints following the ingestion of caffeinated 
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Figure 4. Mean individual peak (a) and mean (b) power output during repeated cycling sprints
following the ingestion of caffeinated coffee, caffeine, placebo and a control condition.
Mean RPE was imilar for all trials (Mean RPE: CAF: 11 ± 2, COF: 11 ± 2, PLA: 11 ± 2 and
CON: 11 ± 2; F3, = 0.154; p = 0.927; η2P = 0.01), although there was a moderate significant increase
throughout the protocol (F17,187 = 3.588; p 33; η2P = 0.73; Figure 5). No significant differences in
blood lactate concentration between trials were observed (F3,33 = 0.979; p = 0.415; η2P = 0.08), although
there was a significant m in effect of time (F1,11 = 48.628; p < 0.001; η2P = 0.82), with a large increase
post-exercise (Figure 6).
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4. Discussion
The aim of the present study was to determine the effect of ingesting caffeine-dose-matched
anhydrous caffeine or coffee on the performance of repeated sprints on a cycle ergometer. The main
findings are that neither COF nor CAF improved repeated sprint performance compared with PLA
and CON. In addition, RPE and blood lactate concentration were unaffected by the ingestion of COF
or CAF.
Peak power output and mean power output were not significantly different during the trials
in which caffeine or coffee was consumed when compared to the placebo and control trials.
In contrast, Trexler et al. [22] reported that caffeine and coffee ingestion improved sprint performance;
however, a dose of 300 mg caffeine was ingested in this study and therefore participants will have
consumed differing amounts of caffeine relative to their body mass. Similarly, Hodgson, Randell
and Jeukendrup [21] observed that coffee and caffeine ingestion improved exercise performance by
comparable magnitudes. One potential explanation for the contrasting findings is the dose of caffeine
ingestion, with values ranging from ~2 to 13 mg·kg−1 of caffeine [28].
One of the proposed mechanisms for improved performance during exercise associated with
caffeine ingestion is fatigue resistance [16]. Schneiker et al. [26] demonstrated that caffeine may cause
fatigue resistance due to enriching the sodium-potassium pump within skeletal muscle. However,
in the present study, peak and mean power output declined by a similar magnitude in all trials.
Paton, Hopkins and Vollebregt [8] hypothesised that caffeine may actually have a negative effect
in terms of fatigue on repeated exercise. This observation was also noted by Greer, McLean and
Graham [34] who suggested that a dose of more than 6 mg·kg−1 of caffeine may be necessary to
elicit an ergogenic response. Greer, McLean and Graham [34] also suggest that an initial increase in
performance after caffeine ingestion may lead to fatigue developing quicker, although the finding of
the present study do not support this hypothesis.
Another potential reason for the absence of an ergogenic effect following the ingestion of caffeine
or coffee is training status. Crowe, Leicht and Spinks [35] suggest that the training status of participants
has a substantial effect on short-term high-intensity performance. Therefore, it could be suggested that
caffeine enhances performance in studies involving trained participants only, which has been observed
by Schneiker et al. [26] and others [2–4,22]. Collomp et al. [36] suggested that specific training may be
Sports 2016, 4, 45 7 of 9
required to elicit ergogenic benefits from caffeine; improved performance in trained 100 m swimmers
was observed following caffeine supplementation, but this improvement was not seen in untrained
swimmers. Therefore, specific physiological adaptations to high-intensity exercise, such as enhanced
regulation of the acid-base balance, may be necessary for caffeine to exert an ergogenic benefit [36].
The current study used recreationally trained participants who participated regularly in multiple
sprint sports. It may therefore be possible that the variation in training backgrounds of participants
in the present study contributed to the absence of an ergogenic effect of caffeine. Furthermore, this
observation may also be related to the increased performance variability in untrained participants [36].
Habituation to caffeine and coffee may also have an impact on the results of the study [37].
Tarnopolsky et al. [38] demonstrated that the ergogenic effects of caffeine may not be seen in habitual
caffeine users due to caffeine tolerance. It has been shown that those individuals who consume
caffeine on a long term basis gain additional adenosine receptors [1]; this therefore suggests that these
individuals would need to consume more caffeine for the same ergogenic effect. Two previous
studies [39,40], in which participants were trained in the activity, produced contrasting results
suggesting that prior habituation to caffeine is a significant factor. One suggestion for this occurrence
is that Woolf, Bidwell and Carlson [39] focused only on ‘caffeine naïve’ participants, and demonstrated
no ergogenic effect of caffeine during high-intensity exercise tests. However, one limitation of the
present study is that habitual caffeine intake was not assessed, so this explanation is only speculative.
Therefore, it would be useful for future studies to assess caffeine sensitivity.
Previous studies have indicated that caffeine generally lowers RPE [18,40], yet there were no
differences in RPE observed in the present study. Furthermore, Glaister et al. [41] reported no significant
differences in RPE during repeated sprints. An explanation for the lack of variation in RPE between
conditions may be that during near maximal sprint efforts, differences may be not observed by
participants as a ‘ceiling effect’ is created [42], therefore there is limited scope for improvement.
Although research demonstrates a positive effect during endurance activities, the results of this
study reveal no effect of caffeine or coffee ingestion during repeated sprint performance in relatively
untrained males. Therefore, trained athletes may be more suitable to the ergogenic effects of caffeine
during high intensity exercise. In addition, considerations regarding caffeine dosage, sex, type and
duration of exercise are also required.
5. Conclusions
Neither COF nor CAF, providing 3 mg·kg−1 of caffeine, improved repeated sprint performance
compared with PLA and CON. In addition, RPE and blood lactate concentration were unaffected by the
ingestion of COF or CAF. Therefore, anhydrous caffeine and coffee ingestion, at this dose, may not be
beneficial pre-exercise nutritional strategies for repeated sprint activity in relatively untrained males.
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primary responsibility for the final content. All authors have read and approved the manuscript.
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